Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.60558 | 80 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.61756 | 79 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.67321 | 80 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.58753 | 85 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.25702 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.48707 | 80 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.27781 | 69 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.52305 | 79 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.66127 | 80 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.54432 | 79 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.53578 | 79 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.58648 | 79 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.32856 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.5289 | 79 |